Julie R. Park

Also affiliated with Seattle Children's Hospital, Center for Cancer and Blood Disorders

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.361Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0293

Top 49%

0.361DataRank

Top 49%7 citations

Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park +4 more

Papers

Driven by 34 papers — median percentile 51. Top paper: “Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects”.

Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0501

N/A

0.886DataRank · unranked

26 citations

Ashley Wilson, Colleen Annesley, Gabriella R. Kimmerly, Corinne Summers, Adam Brand +14 more

A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0293

Top 49%

0.361DataRank

Top 49%7 citations

Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park +4 more

Segmental chromosome aberrations and clinical response impact outcome of inss stage III patients ≥18 months with unfavorable histology and without MYCN amplification: A Children’s Oncology Group (COG) report.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10502

N/A

0DataRank · unranked

0 citations

Arlene Naranjo, Emily Hibbitts, Xiangming Ding, Rachelle Tibbetts, Rebekah Kennedy +7 more

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10523

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Wendy B. London, Sheena C. Tenney +11 more

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3909

N/A

0DataRank · unranked

216 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.006

N/A

0DataRank · unranked

33 citations

Arlene Naranjo, Rochelle Bagatell, Steven G. DuBois, Jeannine S. McCune, Sheena C. Tenney +17 more

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

Blood Advances(2022)10.1182/bloodadvances.2022008119

N/A

0DataRank · unranked

32 citations

Stephanie Rawlings-Rhea, Ashley Wilson, Niklas M. Tulberg, Amber L. Sherman, Kristy Seidel +5 more

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

Cancer(2022)10.1002/cncr.34445

N/A

0DataRank · unranked

14 citations

Judith G. Villablanca, Barbara Hero, Brian H. Kushner, Keith Wheatley, Klaus Beiske +9 more

Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10041

N/A

0DataRank · unranked

0 citations

Yaël P. Mossé, Kimberly Kayser, Yueh‐Yun Chi, Marc Chioda, Holger Thurm +14 more

Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10027

N/A

0DataRank · unranked

0 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Clinical and biologic predictors of response to MIBG therapy: A report from the new approaches to neuroblastoma therapy (NANT) consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e22003

N/A

0DataRank · unranked

0 citations

Katherine K. Matthay, Susan Groshen, Yueh‐Yun Chi, Meaghan Granger, Julie R. Park +3 more

Tumor inflammation-associated neurotoxicity

Nature Medicine(2023)10.1038/s41591-023-02276-w

N/A

0DataRank · unranked

150 citations

Jörg Dietrich, Karin Straathof, Claire Roddie, Brian J. Scott, Tom B. Davidson +17 more

Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety

Neoplasia(2023)10.1016/j.neo.2022.100870

N/A

0DataRank · unranked

32 citations

Rebecca Ronsley, Michelle Choe, Casey Henson, Mandy Breedt, Adriel Barrios-Anderson +25 more

Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.022

N/A

0DataRank · unranked

30 citations

Lena E. Winestone, Erin Sullivan, Qian Wu, Adam J. Lamble, Mark C. Walters +10 more

Impact of diagnostic and end‐of‐induction Curie scores with tandem high‐dose chemotherapy and autologous transplants for metastatic high‐risk neuroblastoma: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30418

N/A

0DataRank · unranked

10 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Factors influencing parents’ choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi‐site longitudinal survey study

Cancer(2023)10.1002/cncr.35149

N/A

0DataRank · unranked

10 citations

Jesse Smith, Yiwang Zhou, Rochelle Bagatell, Justin N. Baker, Susan L. Cohn +10 more

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I‐MIBG in patients with relapsed/refractory neuroblastoma

Pediatric Blood & Cancer(2023)10.1002/pbc.30743

N/A

0DataRank · unranked

5 citations

Ajami Gikandi, Bruce Pawel, Daniel Martínez, Meaghan Granger, Araz Marachelian +6 more

The Plasma Membrane Monoamine Transporter is Highly Expressed in Neuroblastoma and Functions as an mIBG Transporter

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.123.001672

N/A

0DataRank · unranked

4 citations

Yuchen Zhang, Antonio Quinones, Tao Hu, Dilip Kumar Singh, Jeffrey Stevens +4 more

Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data

Current Oncology Reports(2023)10.1007/s11912-023-01423-3

N/A

0DataRank · unranked

1 citations

Ashley Wilson, Tom B. Davidson, Sophia Tahiri, Juliane Gust, Andrea M. Griesinger +8 more

The Plasma Membrane Monoamine Transporter (PMAT) is Highly Expressed in Neuroblastoma and Functions as a Mitochondrial mIBG Transporter

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.203010

N/A

0DataRank · unranked

1 citations

Yuchen Zhang, Antonio Quinones, Julie R. Park, Joanne Wang, Leticia Vieira

Pediatric oncologist referral practices for CAR T-cell therapy: A mixed methods study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10026

N/A

0DataRank · unranked

1 citations

Devan M. Duenas, Jenna Voutsinas, Vicky Wu, Adam J. Lamble, Benjamin S. Wilfond +4 more

Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

(2023)10.1158/1078-0432.c.6531294

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

(2023)10.1158/1078-0432.c.6531294.v1

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high‐risk neuroblastoma clinical trial

Pediatric Blood & Cancer(2023)10.1002/pbc.30658

N/A

0DataRank · unranked

0 citations

Huiyun Wu, Jianrong Wu, Arlene Naranjo, Vinay M. Daryani, Amar Gajjar +3 more

Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

Journal of Pediatric Surgery(2024)10.1016/j.jpedsurg.2024.161896

N/A

0DataRank · unranked

6 citations

E. Stanton Adkins, Peter Mattei, Fredric A. Hoffer, Sandra L. Wootton‐Gorges, Wendy B. London +14 more

A subset of image‐defined risk factors predict completeness of resection in children with high‐risk neuroblastoma: An international multicenter study

Pediatric Blood & Cancer(2024)10.1002/pbc.31218

N/A

0DataRank · unranked

6 citations

Rochelle Bagatell, Kieran McHugh, Arlene Naranjo, Collin Van Ryn, Yesenia Rojas +20 more

Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae063

N/A

0DataRank · unranked

2 citations

Devan M. Duenas, Jenna Voutsinas, Qian Wu, Adam J. Lamble, Elizabeth Gruber +5 more

Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with 4hydroxycyclophosphamide formation in children with Cancer

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04703-2

N/A

0DataRank · unranked

2 citations

Navin Pinto, Douglas S. Hawkins, Julie R. Park, Saam Dilmaghani, Christine F. Rimorin +3 more

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.02.022

N/A

0DataRank · unranked

1 citations

Michael D. Keller, Jennifer Michlitsch, Paibel Aguayo‐Hiraldo, Karin Chen, Mohammad Zahid Hossain +5 more

Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531

Pediatric Blood & Cancer(2024)10.1002/pbc.31407

N/A

0DataRank · unranked

1 citations

Howard M. Katzenstein, Arlene Naranjo, Sheena C. Tenney, Lulu Chen, Wendy B. London +11 more

Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.10003

N/A

0DataRank · unranked

1 citations

Navin Pinto, Arlene Naranjo, Jed G. Nuchtern, Edward F. Attiyeh, Rochelle Bagatell +12 more

Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group

European Journal of Cancer(2020)10.1016/j.ejca.2020.04.007

N/A

0DataRank · unranked

31 citations

Arlene Naranjo, Emily Hibbitts, Julie M. Gastier‐Foster, Rochelle Bagatell, Meredith S. Irwin +5 more

Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships

Journal of Clinical Investigation(2025)10.1172/jci198165

N/A

0DataRank · unranked

3 citations

Leor Needleman, Julie R. Park, Rebecca C. Schugar, Qianjin Guo, James M. Ford +2 more

Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10500

N/A

0DataRank · unranked

4 citations

Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more

Julie R. Park

Indexed papers

Top data-sharing exemplar

Papers